Cardinal Health (CAH) Lifts Earnings Outlook, Is The Stock Still Trading At A Discount?
Alpha Vantage · Simply Wall St · · AI-summarised by FinFlash
Cardinal Health (CAH) recently reported strong quarterly results, with operating income up over a third and adjusted earnings per share increasing by 37%, driven by growth in its Pharmaceutical and Specialty Solutions segment. Despite a significant stock price increase year-to-date, the company is considered 8% undervalued by some analyses, trading at $250.48 against a fair value of $270.94.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.